260 related articles for article (PubMed ID: 23812757)
1. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development.
Chen H; Brady Ridgway J; Sai T; Lai J; Warming S; Chen H; Roose-Girma M; Zhang G; Shou W; Yan M
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11887-92. PubMed ID: 23812757
[TBL] [Abstract][Full Text] [Related]
2. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
[TBL] [Abstract][Full Text] [Related]
3. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound forms.
Salmon RM; Guo J; Wood JH; Tong Z; Beech JS; Lawera A; Yu M; Grainger DJ; Reckless J; Morrell NW; Li W
Nat Commun; 2020 Apr; 11(1):1621. PubMed ID: 32238803
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2.
Mitrofan CG; Appleby SL; Nash GB; Mallat Z; Chilvers ER; Upton PD; Morrell NW
J Biol Chem; 2017 Aug; 292(33):13714-13726. PubMed ID: 28646109
[TBL] [Abstract][Full Text] [Related]
7. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
[TBL] [Abstract][Full Text] [Related]
8. BMP9 and BMP10: Two close vascular quiescence partners that stand out.
Desroches-Castan A; Tillet E; Bouvard C; Bailly S
Dev Dyn; 2022 Jan; 251(1):178-197. PubMed ID: 34240497
[TBL] [Abstract][Full Text] [Related]
9. Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Araki M; Hisamitsu T; Kinugasa-Katayama Y; Tanaka T; Harada Y; Nakao S; Hanada S; Ishii S; Fujita M; Kawamura T; Saito Y; Nishiyama K; Watanabe Y; Nakagawa O
Angiogenesis; 2018 May; 21(2):415-423. PubMed ID: 29478089
[TBL] [Abstract][Full Text] [Related]
10. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
[TBL] [Abstract][Full Text] [Related]
11. Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10.
Bouvard C; Tu L; Rossi M; Desroches-Castan A; Berrebeh N; Helfer E; Roelants C; Liu H; Ouarné M; Chaumontel N; Mallet C; Battail C; Bikfalvi A; Humbert M; Savale L; Daubon T; Perret P; Tillet E; Guignabert C; Bailly S
Cardiovasc Res; 2022 Jun; 118(7):1805-1820. PubMed ID: 34086873
[TBL] [Abstract][Full Text] [Related]
12. BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.
Wang L; Rice M; Swist S; Kubin T; Wu F; Wang S; Kraut S; Weissmann N; Böttger T; Wheeler M; Schneider A; Braun T
Circulation; 2021 Apr; 143(14):1394-1410. PubMed ID: 33334130
[TBL] [Abstract][Full Text] [Related]
13. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
David L; Mallet C; Mazerbourg S; Feige JJ; Bailly S
Blood; 2007 Mar; 109(5):1953-61. PubMed ID: 17068149
[TBL] [Abstract][Full Text] [Related]
14. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
[TBL] [Abstract][Full Text] [Related]
15. Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis.
Somekawa S; Imagawa K; Hayashi H; Sakabe M; Ioka T; Sato GE; Inada K; Iwamoto T; Mori T; Uemura S; Nakagawa O; Saito Y
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12064-9. PubMed ID: 22783020
[TBL] [Abstract][Full Text] [Related]
16. BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance.
Capasso TL; Li B; Volek HJ; Khalid W; Rochon ER; Anbalagan A; Herdman C; Yost HJ; Villanueva FS; Kim K; Roman BL
Angiogenesis; 2020 May; 23(2):203-220. PubMed ID: 31828546
[TBL] [Abstract][Full Text] [Related]
17. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
[TBL] [Abstract][Full Text] [Related]
18. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
[TBL] [Abstract][Full Text] [Related]
19. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II.
Kim JH; Peacock MR; George SC; Hughes CC
Angiogenesis; 2012 Sep; 15(3):497-509. PubMed ID: 22622516
[TBL] [Abstract][Full Text] [Related]
20. Endothelial protective factors BMP9 and BMP10 inhibit CCL2 release by human vascular endothelial cells.
Upton PD; Park JES; De Souza PM; Davies RJ; Griffiths MJD; Wort SJ; Morrell NW
J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32576665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
